Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity (vol 10, 1012, 2020)

Author(s):
Manna, F. la; Menna, M. de; Patel, N.; Karkampouna, S.; Filippo, M.R. de; Klima, I.; Kloen, P.; Beimers, L.; Thalmann, G.N.; Pelger, R.C.M. (0000-0001-6328-6462); Jacinto, E.; Kruithof-de Julio, M.
Published
2021
Publication type
Other
bone metastasisPDXmTORdisulfiramprostate cancerALDH
Date issued
2021-02-03
Language
English
Publisher
FRONTIERS MEDIA SA
hdl
1887/3278609
doi
10.3389/fonc.2021.650623